
Within Range: Demystifying Diabetes Tech for Healthcare Professionals
RADIANT Trial Results: The Impact on Type 1 Diabetes (T1D) Patients and a Glimpse into the Future of Diabetes Care
<p>What happens when you transition type 1 diabetes (T1D) patients from multiple daily injections (MDI) to Omnipod 5 using Abbott’s Freestyle Libre 2? That is exactly what the RADIANT Randomized Controlled Trial (RCT) investigated. </p> <p>Listen to Within Range with Kate Neal, Clinical Services Manager at Insulet who is joined by Dr. Emma Wilmot - Associate Professor at University of Nottingham, consultant Diabetologist, & founder of the Diabetes Technology Network UK - to unpack the incredible results of the RADIANT trial and discuss its impact on patients and the future of diabetes care. </p> <p>Recently published in The Lancet Diabetes & Endocrinology journal, ...





